Enhancement of gastrointestinal absorption of poorly water soluble drugs via lipid based systems

Indian Journal of Experimental Biology

Volumn 42, Issue 11, 2004, Pages 1056-1065

  Subramanian, Natesan ^a   Ghosal, Saroj K ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Gastrointestinal absorption; Lipid based system; Poorly water soluble drugs

Indexed keywords

ABSORPTION; BIOLOGICAL ORGANS; DIGESTIVE SYSTEM; LIPIDS; PHYSIOLOGY; SOLUBILITY;

GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRACTS (GIT); LIPOPHILIC DRUGS; SYNTHETIC LIPIDS;

DRUG PRODUCTS;

DRUG; LIPID; WATER;

ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; GASTROINTESTINAL TRACT; HUMAN; INTESTINE ABSORPTION; METABOLISM; REVIEW; SOLUBILITY;

ANIMALS; DRUG DELIVERY SYSTEMS; GASTROINTESTINAL TRACT; HUMANS; INTESTINAL ABSORPTION; LIPIDS; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; WATER;

EID: 8144225703     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Borman B, Combinatorial chemistry, Chem Eng News, 6 (1998) 47.
2. Lipinski C A, Strategies for optimizing oral drug delivery, Kobe, 4 (1999) 19.
3. Stuchlik M & Zak S, Lipid based vehicle for oral drug delivery, Biomed papers, 145 (2001) 17.
4. Humberstone A J & Charman W N, Lipid-based vehicles for the oral delivery of poorly water soluble drugs, Adv Drug Deliv Rev, 25 (1997) 103.
5. Carey M C, Small D M & Bliss C M, Lipid digestion and absorption, Annu Rev Physiol, 45 (1983) 651.
6. Moreau M, Laugier R, Gargouri Y, Ferrato F & Verger R, Human preduodenal lipase is entirely of gastric fundic origin, Gastroenterology, 95 (1988) 1221.
7. Abrams C K, Hamosh M, Lee T C, Ansher A F, Collen M J, Lewis J H, Benjamin S B & Hamosh P, Gastric lipase: Localization in the human stomach, Gastroenterology, 95 (1988) 1460.
8. Hamosh M, Scanlon, Ganot D, Likel M, Scanlon K B & Hamosh P, Fat digestion in the newborn: Characterisation of lipase in gastric aspirates of premature and term infants, J Clin Invest, 67 (1981) 838.
9. Liao T H, Hamosh P & Hasmosh M, Fat digestion by lingual lipase: Mechanism of lipolysis in the stomach and upper small intestine, Pediatr Res, 18 (1984) 402.
10. Lowe M E, The structure and function of pancreatic enzymes, in Physiology of the gastrointestinal tract, edited by L R Jhonson (Raven Press, New York) 1994, 1531.
11. Borgstrom B, Importance of phospolipids, pancreatic phospholipase A 2 and fatty acid for digestion of dietary fat, Gastroenterology, 78(1980) 954.
12. Bernback S, Blackberg L & Hernell O, Fatty acids generated by gastric lipase promote human milk triacyglycerol digestion by pancreatic colipase-dependent lipase, Biochem Biophys Acta, 1001 (1989) 286.
13. Rautureau M, Bisalli A & Rimbaud J C, Bile bsalts and lipids in the aqueous intraluminal phase during the digestion of a standard meal in man, Clin Biol, 5 (1981) 417.
14. Cary M C & Small D M, The characteristics of mixed miceller solutions with particular reference to man, Am J Med, 49 (1970) 590.
15. Cary M C & Small D M, Micelle formation by bile salts, Arch Intern Med, 130 (1972) 506.
16. Dietschy J M, Sallee V L & Wilson F A, Unstirred water layers and absorption across the intestinal mucosa, Gastroenterology, 61 (1971) 932.
17. Wilson F A, Sallee V L & Dietschy J M, Unstirred water layers in intestine: Rate determinant of fatty acid from miceller solutions, Science, 174 (1971) 1031.
18. Westergaard H & Dietschy J M, The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the mucosal cell, J Clin Invest, 58 (1976) 97.
19. O 'Driscoll M C, Lipid-based formulations for intestinal lymphatic delivery, Eur J Pharm Sci, 15 (2002) 405.
20. Kiyasu J Y, Bloom B & Chaikoff I L, The portal transport of absorbed fatty acids, J Biol Chem, 199 (1952) 415.
21. Senior J R & Isselbacher K J, Direct esterification of monoglycerides with palmityl coenzyme A by intestinal epithelial subcelluar fractions, J Biol Chem, 237 (1962) 1454.
22. Zilversmit D B, The composition and structure of lymph chylomicrons in dog, rat and man, J Clin Invest, 44 (1965) 1610.
23. Constantinides P P, Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects, Pharm Res, 12 (1995) 1561.
24. Gershanik T & Benita S, Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs, Eur J Pharm Bio-pharm, 50 (2000) 179.
25. Pouton C W, Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems, Eur J Pharm Sci, 11 (2000) S93.
26. Holt D W, Mueller E A, Kovarik J M, Van Breen J B & Kutz K, The pharmacokinetics of sandimmune neoral: A new oral formulation of cyclosporin, Transplant Proc, 26 (1994) 2935.
27. Roman R, So you want to use lipid-based formulations in development, Bull Tech Gattefosse, 92 (1999) 51.
28. Hauss J D, Lipid-based systems for oral drug delivery: Enhancing the bioavailability of poorly water soluble drugs, Am Pharm Rev, 4 (2002) 43.
29. Amidon G L, Lennernas H, Shah V P & Crison J R, A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res, 12 (1995) 413.
30. Oh D M, Curl R L & Amidon G L, Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: A mathematical model, Pharm Res, 10 (1993) 264.
31. Dressman J B, Amidon G L, Reppas C & Shah V P, Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms, Pharm Res, 15 (1998) 11.
32. Meyer M C, Straughn A B, Jarvi E J, Wood G C, Pelsor F R & Shah V P, The bioinequivalence of carbamazepine tablets with a history of clinical failures, Pharm Res, 9 (1992) 1612.
33. Charman W N & Stella V J, Estimating the maximum potential for intestinal lymphatic transport of lipophilic drug molecules, Int J Pharm, 34 (1986) 175.
34. Myers R A & Stella V J, Factors affecting the lymphatic transport of penclomedine (NSC-338720), a lipophilic cytotoxic drug: Comparison to DDT and hexachlorobenzene, Int J Pharm, 80 (1992) 511.
35. Sakai A, Mori N, Shuto S & Suzuki T, Deacylation-reacylation cycle: A possible absorption mechanism for the novel lymphotropic antitumor agent dipalmitoyl-phosphatidylfluorouridine in rats, J Pharm Sci, 82 (1993) 575.
36. Charman W N & Porter C J H, Lipophilic prodrugs designed for intestinal lymphatic transport, Adv Drug Deliv Rev, 19 (1996) 149.
37. Swenson E C & Curatolo W J, Intestinal permeability enhancement for proteins, peptides and other polar drugs: Mechanism and potential toxicity, Adv Drug Deliv Rev, 8 (1992) 39.
38. Osborne W, Middleton C A & Rogers R L, Alcohol free microemulsions, J Dispersion Sci Technol, 9 ( 1988) 415.
39. Kawakami K & Yoshikawa T, Recent development in microemulsion-based formulations, Current Top Colloid Interface Sci, 4 (2001) 153.
40. Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, Nishihara Y & Masuda K, Microemulsion formulation for enhanced absorption of poorly soluble drugs I. Prescription design , J Control Release, 81 (2002) 65.
41. Haque M E, Das A R & Moulik S P, Mixed micelles of sodium deoxycholate and polyoxyethylene sorbitan monooleate (Tween 80), J Colloid Interface Sci, 217 (1999) 1.
42. Lu J R, Su T J, Lawrence M J, Barlow D J, Warisnoicharoen W & Zuberi T, The structure and composition of ethyl hexadecanoate layers spread on aqueous solutions of hexaethylene glycol monododecyl ether, J Phys Chem B, 103 (1999) 4638.
43. Kawakami K, Yoshikawa T, Hayashi T, Nishihara Y & Masuda K, Microemulsion formulation for enhanced absorption of poorly soluble drugs, J Control Release, 81 (2002) 75.
44. Gershanik T, Benzeno S & Benita S, Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge, Pharm Res, 15 (1998) 863.
45. Kim C K, Cho Y J & Gao Z G, Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery, J Control Release, 70 (2001) 149.
46. Kang B K, Lee S J, Chon K S, Jeong Y S, Yuk H S, Khang G, Lee B H & Cho H S, Development of self-microemulsifying drug delivery systems for oral bioavailability enhancement of simvastatin in beagle dogs, Int J Pharm, 274(2004) 65.
47. Greenberg S & Fishman W H, Coenzyme Q10: A new drug for cardiovascular disease, J Clin Pharmacol, 30 (1990) 590.
48. Kommuru T R, Gurley B, Khan M A & Reddy I K, Self emulsifying drug delivery systems (SEDDS) of coenzyme Q: 10 formulation development and bioavailability assessment, Int J Pharm, 212 (2001) 133.
49. Rama Prasad Y V, Puthli S P, Eaimtrakarn S, Ishida M, Yoshikawa Y, Shibata N & Takada K, Enhanced intestinal absorption of vancomycin with Labrasol and Dα-tocopheryl PEG 1000 succinate in rats, J Control Release, 250 (2002) 181.
50. Marshall K W, Practical implications of cyclooxygenase-2-specific inhibitors in orthopedics. Am J Orthop, 28 (1999) 19.
51. Krishnan K, Campbell S, Abdel-Rahman F, Whaley S & Stone W L, Cancer chemoprevention drug targets. Curr Drug Targets, 4 (2003) 45.
52. Paulson S, Vaughn M, Jessen S, Lawal Y, Gresk C, Yan B, Maziasz T, Cook C & Karim A, Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption. J Pharmacol Exp Ther, 297 (2001) 638.
53. Leonard F, Patricia M, Polymorphic crystalline forms of celecoxib, WO 01/42222 A1, 2001.
54. Subramanian N, Ray S, Ghosal S K, Bhadra R & Moulik S P, Formulation design of self-microemulsifying drug delivery systems for improved oral bioavilability of celecoxib, Biol Pharm Bull (accepted).
55. Haus D J, Fogal S E, Ficorilli J V, Price C A, Roy T, Jayara A A & Keirns J J, Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor, J Pharm Sci, 87 (1998) 164.
56. Khoo S M, Edwards G A, Porter C J H & Charman W N, A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine, J Pharm Sci, 90 (2001) 1599.